Abstract 4141840: SOX17 Deficiency is Additive to High Shear Stress in Reducing Endothelial Genes Linked to BMPR2 and NOTCH and Promoting Inflammation in Pulmonary Arterial Hypertension

BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by obliteration of distal pulmonary arteries (PA) in association with endothelial cell (EC) dysfunction, leading to smooth muscle proliferation. SOX17 is a transcription factor (TF) expressed in arterial EC that is critical in vascular development. Deleterious variants causing reduced expression of SOX17 are linked to PAH, particularly in congenital heart defects (CHD) that cause increased PA flow and high shear stress (HSS). HYPOTHESIS: SOX17 deficiency is additive to HSS in compromising PAEC homeostasis and in promoting severe PAH. METHODS: SOX17 was reduced (>70%) by siRNA in primary human PAEC cultured in chamber slides in the IBIDI perfusion system. Computational modeling of distal PA indicated pathological HSS of 100 dyn/cm 2 in CHD with PAH whereas physiological laminar shear stress (LSS) is 15 dyn/cm 2 . EC were preconditioned under LSS for 24h, followed by HSS or LSS for 24h. RESULTS: SOX17 expression was increased under LSS versus static condition, as were known SOX17 target genes (e.g., GJA5 , GJA4 , CGNL1 , JAG1 , and CTNNB1). SOX17 siRNA and HSS similarly reduced SOX17 target genes and when combining SOX17 siRNA with HSS they were further decreased owing to an interaction between SOX17 and ERG, a TF reduced by HSS. Indeed, SOX17 and ERG motifs marked most enhancer and promoter H3K27acetyl marks that were reduced under HSS. We then carried out RNAseq of PAEC to find genes co-regulated by SOX17 and ERG (reduced by siRNA for either TF under LSS), decreased under HSS and more-so with HSS + SOX17 siRNA. Those downregulated included SOX17 targets (e.g., CGNL1 and GJA5 ) and others not previously described, with links to BMPR2 signaling, YAP1 (inducer of BMP ligands and suppressor of NF-kB), SETBP1 (inducer of BMPR2 co-receptor BMPR1b), and TMEM100 and SULT1B1 important in NOTCH signaling and EC specification. We also found novel extracellular matrix target genes, e.g., elastin ( ELN, top DEG ) , HMCN1 , TMTC1 and chromatin remodeler ( TOX) . Among genes upregulated, were NAMPT, FAS, LYN, HPSE related to NF-kB activation and/or inflammation. CONCLUSION: HSS plus SOX17 deficiency profoundly compromises EC homeostatic genes, among which are those affecting BMPR2 and NOTCH pathways, ELN fiber assembly, and those promoting inflammation. This can explain why SOX17 mutations are associated with severe PAH in HSS-related congenital heart defects.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4141840
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4141840: SOX17 Deficiency is Additive to High Shear Stress in Reducing Endothelial Genes Linked to BMPR2 and NOTCH and Promoting Inflammation in Pulmonary Arterial Hypertension

Marlene Rabinovitch, Mauro Lago‐Docampo, Tsutomu Shinohara, Yannick C. Lee-Yow et al.
Circulation
Pulmonary Hypertension Research and Treatments
article

Abstract 4141840: SOX17 Deficiency is Additive to High Shear Stress in Reducing Endothelial Genes Linked to BMPR2 and NOTCH and Promoting Inflammation in Pulmonary Arterial Hypertension

Marlene Rabinovitch, Mauro Lago‐Docampo, Tsutomu Shinohara, Yannick C. Lee-Yow, Kun Guo, Chongyang Zhang, J Engreitz
article en

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by obliteration of distal pulmonary arteries (PA) in association with endothelial cell (EC) dysfunction, leading to smooth muscle proliferation. SOX17 is a transcription factor (TF) expressed in arterial EC that is critical in vascular development. Deleterious variants causing reduced expression of SOX17 are linked to PAH, particularly in congenital heart defects (CHD) that cause increased PA flow and high shear stress (HSS). HYPOTHESIS: SOX17 deficiency is additive to HSS in compromising PAEC homeostasis and in promoting severe PAH. METHODS: SOX17 was reduced (>70%) by siRNA in primary human PAEC cultured in chamber slides in the IBIDI perfusion system. Computational modeling of distal PA indicated pathological HSS of 100 dyn/cm 2 in CHD with PAH whereas physiological laminar shear stress (LSS) is 15 dyn/cm 2 . EC were preconditioned under LSS for 24h, followed by HSS or LSS for 24h. RESULTS: SOX17 expression was increased under LSS versus static condition, as were known SOX17 target genes (e.g., GJA5 , GJA4 , CGNL1 , JAG1 , and CTNNB1). SOX17 siRNA and HSS similarly reduced SOX17 target genes and when combining SOX17 siRNA with HSS they were further decreased owing to an interaction between SOX17 and ERG, a TF reduced by HSS. Indeed, SOX17 and ERG motifs marked most enhancer and promoter H3K27acetyl marks that were reduced under HSS. We then carried out RNAseq of PAEC to find genes co-regulated by SOX17 and ERG (reduced by siRNA for either TF under LSS), decreased under HSS and more-so with HSS + SOX17 siRNA. Those downregulated included SOX17 targets (e.g., CGNL1 and GJA5 ) and others not previously described, with links to BMPR2 signaling, YAP1 (inducer of BMP ligands and suppressor of NF-kB), SETBP1 (inducer of BMPR2 co-receptor BMPR1b), and TMEM100 and SULT1B1 important in NOTCH signaling and EC specification. We also found novel extracellular matrix target genes, e.g., elastin ( ELN, top DEG ) , HMCN1 , TMTC1 and chromatin remodeler ( TOX) . Among genes upregulated, were NAMPT, FAS, LYN, HPSE related to NF-kB activation and/or inflammation. CONCLUSION: HSS plus SOX17 deficiency profoundly compromises EC homeostatic genes, among which are those affecting BMPR2 and NOTCH pathways, ELN fiber assembly, and those promoting inflammation. This can explain why SOX17 mutations are associated with severe PAH in HSS-related congenital heart defects.

CirculationVol. 150(Suppl_1)
Stanford University (US)
Good health and well-being
Openalex Percentile: Top 61%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.